Back

Clinical practice associated with 6-month use of patiromer in patients with heart failure

13 May 2024 (09:00 - 10:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy 5 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ines ARAUJO

Hospital de Sao Francisco Xavier, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
Remote monitoring in a virtual ward safely facilitates the rapid up-titration of prognostic medication for heart failure with reduced ejection fraction patients
Doctor A. Kirupananthavel (London, GB)
Abstract Slides Video
Presentation thumbnail
Single centre 3-year experience in intermittent levosimendan infusion
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
SGLT2i on transthyretin amyloid cardiomyopathy - a new drug for an under-recognized cardiomyopathy
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Initial experience of vericiguat treatment in patients with heart failure and high risk of decompensation.
Doctor M. Groba Marco (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors impact on loop diuretic requirement in a community heart failure cohort
Doctor M. Killian (Waterford, IE)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy 5

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Patiromer use for the treatment of hyperkaliemia in patients with heart failure and chronic kidney disease, real-world experience
thumbnail
Congress Presentation
Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry
thumbnail
Congress Presentation
Patiromer in hyperkalemia management: real-world perspective for spironolactone-untreated patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources